Mediterranean Diet and Knee Osteoarthritis Outcomes: A Longitudinal Cohort Study by Veronese, Nicola et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1016/j.clnu.2018.11.032
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Veronese, N., Koyanagi, A., Stubbs, B., Cooper, C., Guglielmi, G., Rizzoli, R., ... Maggi, S. (2018).
Mediterranean Diet and Knee Osteoarthritis Outcomes: A Longitudinal Cohort Study. CLINICAL NUTRITION.
https://doi.org/10.1016/j.clnu.2018.11.032
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 10. Jul. 2020
Accepted Manuscript
Mediterranean Diet and Knee Osteoarthritis Outcomes: A Longitudinal Cohort Study
Nicola Veronese, MD, Ai Koyanagi, MD, Brendon Stubbs, PhD, Cyrus Cooper, MD,
Giuseppe Guglielmi, MD, Renè Rizzoli, MD, Leonardo Punzi, MD, Domenico Rogoli,
MD, Maria Gabriella Caruso, MD, Ornella Rotolo, RD, Maria Notarnicola, ScD, Nasser
Al-Daghri, MD, Lee Smith, PhD, Jean-Yves Reginster, MD, PhD, Stefania Maggi, MD
PII: S0261-5614(18)32565-2
DOI: https://doi.org/10.1016/j.clnu.2018.11.032
Reference: YCLNU 3699
To appear in: Clinical Nutrition
Received Date: 24 September 2018
Revised Date: 27 November 2018
Accepted Date: 29 November 2018
Please cite this article as: Veronese N, Koyanagi A, Stubbs B, Cooper C, Guglielmi G, Rizzoli R, Punzi
L, Rogoli D, Caruso MG, Rotolo O, Notarnicola M, Al-Daghri N, Smith L, Reginster J-Y, Maggi S,
Mediterranean Diet and Knee Osteoarthritis Outcomes: A Longitudinal Cohort Study, Clinical Nutrition,
https://doi.org/10.1016/j.clnu.2018.11.032.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
1 
 
MEDITERRANEAN DIET AND KNEE OSTEOARTHRITIS OUTCOMES:  1 
A LONGITUDINAL COHORT STUDY 2 
 3 
Nicola Veronese1,2, MD, Ai Koyanagi3,4, MD, Brendon Stubbs5,6,7, PhD, Cyrus Cooper8,9,10, MD, 4 
Giuseppe Guglielmi11,12, MD, Renè Rizzoli13, MD, Leonardo Punzi14, MD, Domenico Rogoli1, MD, 5 
Maria Gabriella Caruso2, MD, Ornella Rotolo2, RD, Maria Notarnicola2, ScD, Nasser Al-Daghri15, 6 
MD, Lee Smith16, PhD, Jean-Yves Reginster15,17, MD, PhD, Stefania Maggi1, MD  7 
 8 
1 National Research Council, Neuroscience Institute, Aging Branch, Padova, Italy. 9 
2 National Institute of Gastroenterology-Research Hospital, Castellana Grotte, Bari, Italy. 10 
3
 Research and Development Unit, Parc Sanitari Sant Joan de Déu, Universitat de Barcelona, 11 
Fundació Sant Joan de Déu, Barcelona, Spain. 12 
4 Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental, 13 
CIBERSAM, Madrid, Spain. 14 
5 Physiotherapy Department, South London and Maudsley NHS Foundation Trust, Denmark Hill, 15 
London SE5 8AZ, UK.  16 
6 Health Service and Population Research Department, Institute of Psychiatry, Psychology and 17 
Neuroscience King's College London, De Crespigny Park, London Box SE5 8AF, UK. 18 
7
 Faculty of Health, Social Care and Education, Anglia Ruskin University, Bishop Hall Lane, 19 
Chelmsford CM1 1SQ, UK. 20 
8 Oxford NIHR Musculoskeletal Biomedical Research Unit, Nuffield Department of Orthopaedics, 21 
Rheumatology and Musculoskeletal Sciences, Nuffield Orthopaedic Centre, University of Oxford, 22 
Windmill Road, Oxford, OX3 7LD, UK. 23 
9 MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton, 24 
Southampton, SO16 6YD, UK. 25 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
2 
 
10 National Institute for Health Research Nutrition Biomedical Research Centre, University of 26 
Southampton and University Hospital Southampton NHS Foundation Trust, Southampton General 27 
Hospital, Southampton, SO16 6YD, UK. 28 
11 Department of Radiology, University of Foggia, Foggia, Italy. 29 
12 Department of Radiology, Scientific Institute "Casa Sollievo della Sofferenza" Hospital, San 30 
Giovanni Rotondo, Foggia, Italy. 31 
13 Division of Bone Diseases, Department of Internal Medicine Specialties, Geneva University 32 
Hospitals and Faculty of Medicine, Geneva, Switzerland. 33 
14
 Rheumatology Unit, Department of Medicine (DIMED), University of Padova, Padova, Italy. 34 
15 Prince Mutaib Chair for Biomarkers of Osteoporosis, Biochemistry Department, College of 35 
Science, King Saud University , Riyadh , Saudi Arabia. 36 
16 The Cambridge Centre for Sport and Exercise Sciences, , Anglia Ruskin University, Cambridge, 37 
UK. 38 
17 Department of Public Health, Epidemiology and Health Economics, University of Liege, CHU 39 
Sart Tilman B23, 4000, Liège, Belgium. 40 
 41 
Corresponding Author: 42 
Nicola Veronese, MD 43 
National Research Council, Neuroscience Institute, Aging Branch 44 
Via Giustiniani, 2 35128 Padova, Italy 45 
Phone: +390498211746; Fax: +390498211218 46 
Email: ilmannato@gmail.com  47 
 48 
Word count: 2314 49 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
3 
 
ABSTRACT 50 
Objectives: Mediterranean diet has several beneficial effects on health, but data regarding the 51 
association between Mediterranean diet and knee osteoarthritis (OA) are limited mainly to cross-52 
sectional studies. We investigated whether higher Mediterranean diet adherence is prospectively 53 
associated with lower risk of radiographic OA (ROA), radiographic symptomatic knee OA (SxOA) 54 
and pain worsening in North American people at high risk or having knee OA.  55 
Methods: Adherence to the Mediterranean diet was evaluated using a validated Mediterranean diet 56 
score (aMED), categorized in five categories. Knee OA outcomes included incident (1) ROA, (2) 57 
SxOA, as the new onset of a combination of a painful knee and ROA, (3) knee pain worsening, i.e. 58 
a Western Ontario and McMaster Universities Osteoarthritis Index difference between baseline and 59 
each annual exam of ≥14%.  60 
Results: 4,330 subjects (mean age: 61.1 years; 58.0% females) were included. Based on a 61 
multivariable Poisson regression analysis, during a mean follow-up period of 4 years, participants 62 
who were more highly adherent to a Mediterranean diet (Q5) reported lower risk of pain worsening 63 
(relative risk, RR=0.96; 95%CI: 0.91-0.999) compared to those in Q1. In 2,994 people free from 64 
SxOA at baseline, higher adherence to a Mediterranean diet was associated with a lower risk for 65 
SxOA during follow-up by 9% (Q5 vs. Q1; RR=0.91; 95%CI: 0.82-0.998). No significant 66 
associations emerged between aMED and incident ROA.  67 
Conclusion: Higher adherence to Mediterranean diet is associated with a lower risk of pain 68 
worsening and symptomatic forms of knee OA.  69 
 70 
Keywords: osteoarthritis; Mediterranean diet; aged; Osteoarthritis Initiative; pain; knee 71 
osteoarthritis.  72 
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INTRODUCTION 73 
With the term “Mediterranean diet”, we commonly refer to the dietary habits typical of people 74 
living in the Mediterranean basin. [1] A growing body of literature  suggests that the Mediterranean 75 
diet has beneficial effects on several health outcomes, including cardiovascular disease [2], 76 
metabolic syndrome [3], diabetes [4], but also musculoskeletal conditions such as 77 
osteoporosis/fracture [5], frailty [6] and sarcopenia. [7] 78 
 79 
However, data regarding the possible association between Mediterranean diet and knee 80 
osteoarthritis (OA) are very limited. Knee OA is one of the most important contributors to global 81 
disability worldwide [8] and its prevalence is overall increasing, particularly in older people, among 82 
whom 10% of men and 20% of women over the age of 60 years suffer from this condition. [9, 10] 83 
Despite this, to the best of our knowledge, only a few cross-sectional studies have studied the 84 
association between higher adherence to Mediterranean diet and knee OA, showing overall that 85 
people following more strictly Mediterranean diets have a significantly lower likelihood of knee 86 
OA and a better knee structure. [11, 12] The Mediterranean diet is rich in vitamins and minerals, 87 
particularly those derived from vegetables and fruits, whole-meal cereals, nuts, virgin olive oil and 88 
fish, which made the risk of deficient micronutrient intakes quite infrequent. This explains why 89 
Mediterranean diet is particularly rich in antioxidant vitamins (vitamins E and C) and carotenes 90 
were also high.[13] In this regard, other research indirectly supported a role of Mediterranean diet 91 
on knee OA. For example, in a large observational study it was found that  participants introducing 92 
higher vitamin C and E and β-carotene in their diet were less likely to have knee OA. [14] 93 
However, cross-sectional studies can suffer “reverse causality” and, consequently, longitudinal 94 
cohort studies are needed to confirm the potential association between Mediterranean diet and knee 95 
OA outcomes.    96 
 97 
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Given this background, we aimed to investigate whether higher adherence to Mediterranean diet is 98 
associated with lower risk of radiographic OA (ROA), radiographic symptomatic knee OA (SxOA) 99 
and pain worsening due to knee OA, in a large cohort of North American people followed-up for 4 100 
years.   101 
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MATERIALS AND METHODS 102 
Data source and subjects 103 
Data were obtained from the Osteoarthritis Initiative (OAI) database. Participants were recruited 104 
across four clinical sites in the United States of America (Baltimore, MD; Pittsburgh, PA; 105 
Pawtucket, RI; and Columbus, OH) between February 2004 and May 2006. In the OAI, individuals 106 
were included if they: (1) had knee OA with knee pain for a 30-day period in the past 12 months or 107 
(2) were at high risk of developing knee OA (e.g. obese/overweight, familiarity for knee OA).[15] 108 
The present study used data collected during the baseline/screening evaluation and in subsequent 109 
evaluations until four years of follow-up. All participants provided written informed consent. The 110 
OAI study was given full ethics approval by the institutional review board of the OAI Coordinating 111 
Center, at the University of California in San Francisco. 112 
 113 
Exposure variable: Adherence to Mediterranean diet  114 
Participants’ diet patterns were collected using the Block Brief 2000 food frequency (FFQ) 115 
questionnaire during the baseline appointment.[16] The validated tool, containing a food list of 70 116 
parameters, was designed to assess  individuals’ food and beverage consumption over the past year. 117 
Frequency of food consumption of the items included was reported at nine levels of intake from 118 
“never” to “every day”. There were also seven dietary behavior questions on food preparation 119 
methods and fat intake, one question on fiber intake, and 13 questions on vitamin and mineral 120 
intakes. 121 
 122 
Adherence to a Mediterranean diet was evaluated by applying the Mediterranean diet score (aMED) 123 
proposed by Panagiotakos et al.[17] to the FFQ. The aMED takes into consideration foods 124 
commonly consumed by Mediterranean populations. Respondents were asked to rate their 125 
consumption of each single food item using a score ranging from 0 (less adherence) to 5 (better 126 
adherence); the total possible score ranges from 0 to 55, with higher values indicating higher 127 
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adherence to a Mediterranean diet. Cereals (e.g. bread, pasta, rice), potatoes, fruits, vegetables, 128 
legumes (e.g. peas, beans), fish were categorized on the basis of servings/month and specifically as: 129 
0=never; 1=1 to 4 servings/month; 2=5 to 8; 3=9 to 12; 4=13 to 18; 5= more than 18 130 
servings/month. As no distinction was made with reference to whole vs. refined cereals, all types of 131 
grains were considered under the same heading. Consumption of red meat, poultry, and full fat 132 
dairy products (e.g. milk cheese, yogurt) were categorized as: 0=more than 18 servings/month; 133 
1=13 to 17 servings/month; 2=9 to 12; 3=5 to 8; 4=1 to 4; 5= never). Consumption of olive oil was 134 
categorized as the times it was used in a week’s time and specifically as: 0=never; 1=rare; 2 135 
≤1/weekly; 3= 2 times/weekly; 4=3 to 6; 5=daily. Alcoholic beverages were categorized as: 0≥700 136 
ml/day or 0; 1=600 to 699 ml/day; 2=500 to 599 ml/day; 3=400 to 499 ml/day; 4=300 to 399 137 
ml/day; 5=< 300 ml/day.   138 
The aMed score was divided into 5 quintiles: aMED score <24 = Q1, 25-27 = Q2, 28-30 = Q3, 31-139 
32 = Q4 and > 32 =Q5. We also modelled aMED as continuous using an increase in one SD (i.e. 5 140 
points).  141 
 142 
Assessment of knee OA outcomes 143 
At baseline and during follow-up examinations, people had full knee assessments which included 144 
both a clinical and radiographic examination. Individuals with knee replacement at baseline were 145 
removed from analyses. A fixed flexion posterior–anterior radiograph, which was read centrally for 146 
Kellgren and Lawrence (KL) grade, was made for all the participants. In addition, participants were 147 
asked regarding knee pain, the following question: ‘During the past 30 days, have you had pain, 148 
aching, or stiffness in your right/left knee on most days?’. Knee pain was also assessed using the 149 
WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) pain subscale. This 150 
scale ranges from 0 (absence of pain) to 20 (highest pain) points.    151 
 152 
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In the present study the following knee outcomes were considered: (1) incident  ROA 153 
(radiographical osteoarthritis), if a knee developed a KL grade ≥2 at follow-up and was not present 154 
at baseline, (2) SxOA (symptomatic osteoarthritis), defined as new onset of a combination of 155 
painful knee plus (determined using the answer yes to the following question: “During the past 30 156 
days, have you had pain, aching, or stiffness in your right/left knee on most days?”) together the 157 
presence of ROA. Both these criteria should be present at the same site and (3) knee pain 158 
worsening, i.e.  WOMAC pain score difference of a knee between baseline and each annual exam 159 
≥14% or the onset of any pain during follow-up in people having zero at baseline in agreement with 160 
previous research regarding this topic.[18-20]  161 
 162 
The assessment of these knee OA outcomes was made, other than at baseline, at V01 (12 months), 163 
V03 (24 months), V05 (36 months), and V06 (48 months). 164 
 165 
Covariates 166 
Ten covariates at baseline (other than age and sex) were identified as potential confounding factors 167 
based on previous literature.[21] These included: race (whites vs. others); educational attainment 168 
(college or higher vs. others); body mass index (BMI); yearly income (< vs > $50,000 or missing 169 
data); depressive symptoms measured using the Center for Epidemiologic Studies Depression Scale 170 
(CES-D)[22]; smoking habits (current and previous vs. never); physical activity level evaluated 171 
using the Physical Activity Scale for the Elderly  (PASE) [23]; Charlson Comorbidity Index score 172 
[24]; daily energy intake; number of medications at baseline. 173 
 174 
Statistical analyses 175 
Continuous variables were normally distributed according to the Kolmogorov-Smirnov test. Data 176 
were presented as means and standard deviation values (SD) for quantitative measures, and 177 
percentages for all categorical variables by aMED scores. P values for trends were calculated using 178 
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the Jonckheere-Terpstra test for continuous variables and the Mantel-Haenszel Chi-square test for 179 
categorical variables. 180 
To assess associations between aMED and the outcomes ROA, SxOA, and pain worsening, a 181 
multivariable Poisson regression analysis with robust variance estimators was applied, since a 182 
survival analysis was not possible due to lack of information on the precise date of event. We used 183 
two models, one not adjusted for any covariate, and one fully-adjusted using the aforementioned 184 
covariates . Multi-collinearity among covariates was assessed through variance inflation factor [25], 185 
taking a cut-off of 2 as the criterion for exclusion. However, no covariates were excluded using this 186 
criterion. Relative risks (RRs) and 95% confidence intervals (CI) were calculated to estimate the 187 
strength of the associations between aMED and incident knee OA outcomes.  188 
 189 
A p<0.05 was deemed statistically significant.  All analyses were performed using SPSS® software 190 
version 17.0 for Windows (SPSS Inc., Chicago, Illinois) and STATA® software version 14.1 (Stata 191 
Corp LP, College station, Texas).  192 
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RESULTS 193 
Sample selection 194 
The OAI dataset initially included a total of 4,796 individuals. We excluded 63 participants with a 195 
total knee replacement at baseline (since they cannot develop any of the outcomes of interest), 118 196 
not having sufficient information for calculating aMED or having implausible calorie intake (<500 197 
or >4000 Kcal) and a further 285 with no data regarding outcomes of interest during follow-up. 198 
Thus, the final sample consisted of 4,330 people (=90.2% of the entire population initially involved 199 
in the OAI).    200 
 201 
Descriptive characteristics  202 
The baseline cohort consisted of 2,510 females (58.0%) and 1,820 males (42.0%), with a mean age 203 
of 61.1 years (±9.2 years; range: 45-79 years). The mean aMED was 28 points (±5 points; range: 0-204 
44). At baseline, 2,491 had knee ROA (=57.5% of baseline population) and, of them, 1,078 had 205 
knee SxOA (=24.9%).  206 
 207 
Table 1 shows the baseline characteristics by aMED score category. People more strictly following 208 
Mediterranean diet (i.e. included in Q5) were significantly older, more frequently females and 209 
whites, more frequently physical active and educated than those having lower scores (=Q1). 210 
Moreover, those in Q5 were less obese and depressed, reported lower presence of medical 211 
conditions and used less medications than those included in the first category. 212 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
11 
 
Table 1. Descriptive findings of the participants by adherence to Mediterranean diet.  213 
 
Q1 
(n=1044) 
aMED<24 
Q2 
(n=872) 
aMED 25-27 
Q3 
(n=973) 
aMED 28-30 
Q4 
(n=583) 
aMED 31-32 
Q5 
(n=858) 
aMED > 32 
P value* 
Energy intake (Kcal/day) 1522 (533) 1469 (510) 1510 (540) 1497 (511) 1492 (484) 0.32 
Age (years) 59.0 (8.8) 61.1 (8.9) 61.5 (9.2) 62.4 (9.1) 63.0 (9.1) <0.0001 
PASE (points) 160 (84) 162 (80) 167 (84) 153 (77) 163 (82) 0.02 
Females (n, %) 532 (51.0) 519 (59.5) 585 (60.1) 341 (58.5) 533 (62.1) <0.0001 
White race (n, %) 731 (70.1) 681 (78.2) 798 (82.1) 506 (86.8) 751 (87.6) <0.0001 
Smoking (previous/current) 473 (45.6) 405 (46.7) 445 (46.1) 284 (48.9) 419 (49.2) 0.45 
Graduate degree (n, %) 246 (23.6) 257 (29.5) 290 (29.8) 205 (35.2) 328 (38.2) <0.0001 
Yearly income (< 50,000 $) 554 (53.1) 517 (59.3) 583 (59.9) 370 (63.5) 552 (64.3) <0.0001 
BMI (Kg/m2) 29.8 (4.9) 29.2 (4.8) 28.3 (4.6) 28.1 (4.7) 27.4 (4.5) <0.0001 
CES-D (points) 7.4 (7.89 6.5 (6.8) 6.5 (6.7) 6.0 (6.1) 6.1 (6.4) <0.0001 
Charlson co-morbidity index (points) 0.4 (0.9) 0.4 (0.9) 0.4 (0.8) 0.3 (0.7) 0.3 (0.8) 0.02 
Number of medications (points) 2.9 (2.8) 3.2 (2.7) 3.0 (2.7) 3.0 (2.6) 2.8 (2.6) 0.05 
 214 
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Abbreviations: aMED: adherence to Mediterranean diet score; PASE: Physical Activity Scale for the Elderly; BMI: body mass index; WOMAC: 215 
Western Ontario & McMaster Universities Osteoarthritis   216 
* P values for trends were calculated using the Jonckheere-Terpstra test for continuous variables and the Mantel-Haenszel Chi-square test for 217 
categorical variables.  218 
Data are means (with standard deviation) or number (and percentage) as appropriate.  219 
Q1 indicates participants having the lowest adherence to Mediterranean diet; Q5 the highest.   220 
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Mediterranean diet adherence and incident knee osteoarthritis outcomes 221 
As shown in Table 2, during a mean follow-up period of 4 years, after adjusting for several potential confounders at baseline, participants in Q5 (i.e. 222 
those having a higher adherence to Mediterranean diet) reported a significantly lower risk for pain worsening (RR=0.96; 95%CI: 0.91-0.999; 223 
p=0.047) compared to those in Q1. Each increase in one SD (i.e. 5 points) was associated with a significantly lower risk of pain worsening by 2% 224 
(RR=0.98; 95%CI: 0.97-0.998; p=0.04) (Table 2).   225 
In 2,994 subjects free from SxOA at the baseline, higher adherence to Mediterranean diet was associated with a significantly lower risk for SxOA 226 
during follow-up by 9% (RR=0.91; 95%CI: 0.82-0.998; p=0.048) and each one SD increase in aMED lowered the risk for this outcome by 4%.  227 
 228 
On the contrary, no significant associations emerged between aMED and incident ROA, as shown in Table 2.   229 
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Table 2. Association between adherence to Mediterranean diet and incident knee outcomes 230 
 
Basic adjusted 
RR 
(95%CI) 
P value 
Fully adjusted 
RR1 
(95%CI) 
P value 
Pain worsening (n=4,227 at baseline) 
aMED <24 1 [reference] 1 [reference] 
aMED 25-27 0.98 (0.94-1.02) 0.27 0.98 (0.95-1.02) 0.45 
aMED 28-30 0.99 (0.95-1.02) 0.46 0.99 (0.95-1.03) 0.72 
aMED 31-32 0.98 (0.94-1.02) 0.34 0.99 (0.94-1.03) 0.53 
aMED >32 0.95 (0.91-0.99) 0.01 0.96 (0.91-0.999) 0.047 
Increase in one SD 0.98 (0.97-0.995) 0.01 0.98 (0.97-0.998) 0.04 
Symptomatic knee OA (n=2,994 at baseline)  
aMED <24 1 [reference] 1 [reference] 
aMED 25-27 0.92 (0.82-1.008) 0.07 0.94 (0.85-1.04) 0.25 
aMED 28-30 0.86 (0.78-0.95) 0.003 0.91 (0.82-1.009) 0.07 
aMED 31-32 0.86 (0.77-0.97) 0.01 0.93 (0.83-1.05) 0.26 
aMED >32 0.83 (0.75-0.92) 0.001 0.91 (0.82-0.998) 0.048 
Increase in one SD 0.93 (0.89-0.96) <0.0001 0.96 (0.93-0.997) 0.04 
Radiographic knee OA (n=1,796 at baseline) 
aMED <24 1 [reference] 1 [reference] 
aMED 25-27 1.32 (0.89-1.96) 0.17 1.32 (0.88-1.98) 0.19 
aMED 28-30 1.18 (0.79-1.75) 0.42 1.14 (0.75-1.74) 0.54 
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 231 
1 Fully adjusted model included as covariates: age (as continuous); sex; race (whites vs. others); education (degree vs. others); body mass index (as 232 
continuous); yearly income (categorized as > or < 50,000$ and missing data); CES-D: Center for Epidemiologic Studies Depression Scale; smoking 233 
habits (current and previous vs. others); Physical Activity Scale for Elderly score (as continuous); Charlson co-morbidity index; number of 234 
medications used; daily energy intake.235 
aMED 31-32 0.98 (0.61-1.59) 0.95 1.03 (0.63-1.68) 0.91 
aMED >32 1.06 (0.70-1.59) 0.80 1.13 (0.72-1.78) 0.59 
Increase in one SD 0.96 (0.84-1.09) 0.51 1.00 (0.86-1.16) 0.99 
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DISCUSSION 236 
In this large longitudinal study over a 4-year follow-up period, our results suggest that higher 237 
adherence to Mediterranean diet is associated with a significantly lower risk of pain worsening and 238 
symptomatic knee OA, whilst no significant effect was observed on the incidence of radiographic 239 
knee OA. 240 
 241 
Although knee OA is a common condition and diet seems to play a pivotal role in the prevention 242 
and in supporting the treatment of this condition [26], the data regarding the potential association 243 
between higher adherence to Mediterranean diet and knee OA are, unfortunately, limited. In the 244 
Osteoarthritis Initiative, we have already reported that higher aMED scores were not only 245 
associated with a significant lower prevalence of knee OA (also after accounting for potential 246 
confounders) [12], but also with a better architecture of the knee, investigated through a magnetic 247 
resonance investigation.[11] However these data were cross-sectional limiting the interpretation of 248 
these findings. With the current research, we have further reinforced the concept that Mediterranean 249 
diet could be useful for the prevention of pain in knee OA and for the symptomatic forms through a 250 
longitudinal design.    251 
 252 
We can hypothesize several mechanisms that may explain the association between adherence to 253 
Mediterranean diet and reduction in pain/symptomatic knee OA. First, a stricter adherence to a 254 
Mediterranean diet has been shown to be associated with an important decrease in inflammatory 255 
parameters [27] and it is widely known that inflammation plays a pivotal role in the destruction of 256 
knee cartilage. [28] This effect (i.e. anti-inflammatory) seems to be the most important factor in the 257 
link between Mediterranean diet and knee OA, as also confirmed by a small randomized controlled 258 
trial showing that people following a Mediterranean diet regimen had a significant decrease in IL1a, 259 
a potent pro-inflammatory cytokine.[29] In this sense, the anti-inflammatory properties typical of a 260 
Mediterranean diet may consequently reduce pain and symptomatic forms of knee OA. Similarly, 261 
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following a Mediterranean diet seems to lower oxidative stress markers [30], which may influence 262 
the onset of symptomatic OA by enhancing collagen type II and aggrecan expression levels and 263 
inhibiting apoptosis-related protein expression. [30] Third, the Mediterranean diet is particularly 264 
rich in some nutrients that may have a protective effect on knee OA outcomes, such as fibers and 265 
vitamins. For example, a previous study  reported that dietary fibers, particularly present in 266 
Mediterranean diet, are able to prevent/improve several knee OA outcomes. [19] Finally, 267 
Mediterranean diet seems to have a role in improving the extracellular matrix (ECM) [30], 268 
consequently promoting the effective repair of a structure which is frequently reduced in people 269 
developing knee OA. In animal models, it was reported that the use of olive oil, a pivotal 270 
component of Mediterranean diet, significantly improved articular cartilage structure, indicating a 271 
potential role of diets rich in this component for knee OA outcomes. [31] 272 
 273 
The long duration of follow-up, the multiple knee OA outcomes included, and the large sample size 274 
are clear strengths of the present study. However, findings from the present study should be 275 
interpreted in light of  its limitations. First, participants recruited into the OAI were either at high 276 
risk of developing or already had knee OA. Thus, further research in the general population is 277 
needed to confirm our findings. Second, our findings are observational and, although we tried to 278 
overcome this limitation using analyses adjusted for potential confounders, we cannot exclude 279 
potential bias. In this sense, of particular importance is that dietary questionnaires can suffer recall 280 
bias.[32] Finally, the record of medications and comorbidities is self-reported and, again, we cannot 281 
exclude a potential bias for these parameters.  282 
 283 
In conclusion, our data suggest that, higher adherence to Mediterranean diet is associated with a 284 
lower risk of pain worsening and symptomatic forms of knee OA, whilst no significant association 285 
emerged when taking radiographic knee OA as outcome. Although our research provides further 286 
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evidence on the important role of Mediterranean diet on knee OA outcomes, future RCTs are 287 
needed to confirm or refute our findings.    288 
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